Université du Québec à Trois-Rivières, Podiatric Medicine Program, 3351, Boul. des Forges, C.P.500, Trois-Rivières, Québec G8Z 4M3, Canada.
Innofibre, Cégep de Trois-Rivières, 3351 Boul. des Forges, Trois-Rivières, Québec G9A 5E6, Canada.
Biomed Res Int. 2020 Jan 9;2020:1304016. doi: 10.1155/2020/1304016. eCollection 2020.
To evaluate in vitro the antibacterial effect of a paper made of silver phosphate cellulose fibers (SPCF) on , the most common diabetic foot ulceration (DFU) pathogen when compared with other common commercial products.
The antibacterial activity of SPCF samples was evaluated through time with cell counting on agar plates. SPCF samples were then compared with commercial wound care products currently in use in DFU treatments (Silvercel™, Acticoat 7, and Aquacel Ag Extra) through time on agar plates (growth inhibition zones).
After 6 hours, there was no viable bacterial cell detected on either plate ( < 0.05). There was a net growth inhibition zone for SPCF samples but no significant difference between the two silver concentrations. Compared with common commercial products, SPCF paper provides results equal to Acticoat 7 ( < 0.05). There was a net growth inhibition zone for SPCF samples but no significant difference between the two silver concentrations. Compared with common commercial products, SPCF paper provides results equal to Acticoat 7 ( < 0.05). There was a net growth inhibition zone for SPCF samples but no significant difference between the two silver concentrations. Compared with common commercial products, SPCF paper provides results equal to Acticoat 7 (.
These results have shown the efficiency of SPCF paper to eliminate in these conditions. SPCF papers are effective when compared with other common commercial products and could have an industrial potential in wound care. Infected DFU could benefit from the antibacterial effectiveness of SPCF, but more relevant experimentations related to foot ulcers are needed., the most common diabetic foot ulceration (DFU) pathogen when compared with other common commercial products.
评估磷酸银纤维素纤维纸(SPCF)对 ,与其他常见商业产品相比,作为最常见的糖尿病足溃疡(DFU)病原体的体外抗菌效果。
通过琼脂平板细胞计数评估 SPCF 样品的抗菌活性。然后,通过琼脂平板(生长抑制区)比较 SPCF 样品与目前用于 DFU 治疗的商业伤口护理产品(Silvercel™、Acticoat 7 和 Aquacel Ag Extra)的时间差异。
6 小时后,两种平板上均未检测到存活的细菌细胞(<0.05)。SPCF 样品有净生长抑制区,但两种银浓度之间无显著差异。与常见商业产品相比,SPCF 纸的结果与 Acticoat 7 相当(<0.05)。SPCF 样品有净生长抑制区,但两种银浓度之间无显著差异。与常见商业产品相比,SPCF 纸的结果与 Acticoat 7 相当(<0.05)。SPCF 样品有净生长抑制区,但两种银浓度之间无显著差异。与常见商业产品相比,SPCF 纸的结果与 Acticoat 7 相当(<0.05)。
这些结果表明 SPCF 纸在这些条件下有效消除 。与其他常见商业产品相比,SPCF 纸具有高效性,在伤口护理方面具有工业潜力。受感染的 DFU 可能受益于 SPCF 的抗菌效果,但需要更多与足部溃疡相关的相关实验。